Results 11 to 20 of about 458 (127)

A Facile Assay for zDHHC Palmitoyl Transferase Activation Elucidates Effects of Mutation and Modification [PDF]

open access: yesJournal of Lipid Research
At least 10% of proteins constituting the human proteome are subject to S-acylation by a long-chain fatty acid, thioesterified to a Cys thiol side chain.
Takehiko Ueyama   +2 more
exaly   +8 more sources

Substrate recruitment by zDHHC protein acyltransferases [PDF]

open access: yesOpen Biology, 2021
Protein palmitoylation is the post-translational attachment of fatty acids, most commonly palmitate (C16 : 0), onto a cysteine residue of a protein. This reaction is catalysed by a family of integral membrane proteins, the zDHHC protein acyltransferases (
Martin Ian P. Malgapo, Maurine E. Linder
doaj   +3 more sources

Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses [PDF]

open access: yesBiomolecules
Protein S-palmitoylation is a pivotal yet poorly integrated research field in dermatology. This reversible post-translational lipid modification primarily occurs on cysteine residues and is principally catalyzed by zinc finger and Asp-His-His-Cys DHHC ...
Feng Y   +9 more
exaly   +4 more sources

Diverse Roles of Protein Palmitoylation in Cancer Progression, Immunity, Stemness, and Beyond [PDF]

open access: yesCells, 2023
Protein S-palmitoylation, a type of post-translational modification, refers to the reversible process of attachment of a fatty acyl chain—a 16-carbon palmitate acid—to the specific cysteine residues on target proteins.
Mingli Li, Chun-Wei Chen
exaly   +4 more sources

Recent Advances in S-Palmitoylation and Its Emerging Roles in Human Diseases [PDF]

open access: yesJournal of Hematology and Oncology
S-palmitoylation, one reversible post-translational modification (PTM) involving the binding of palmitate to proteins, influences protein stability, localization and interactions.
Xiangxiang Zhou, Juanjuan Shang
exaly   +3 more sources

Role of S-Palmitoylation in Digestive System Diseases [PDF]

open access: yesCell Death Discovery
Digestive system diseases, including liver diseases, gastrointestinal cancers, and inflammatory bowel diseases, pose major health challenges worldwide.
Tao Yu, Shuangshuang Wang, Xing-Si Qi
exaly   +3 more sources

zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment Perspective [PDF]

open access: yesInternational Journal of Molecular Sciences
S-acylation, which includes S-palmitoylation, is the only known reversible lipid-based post-translational protein modification. S-palmitoylation is mediated by palmitoyl acyltransferases (PATs), a family of 23 enzymes commonly referred to as zDHHCs, which catalyze the addition of palmitate to cysteine residues on specific target proteins.
Harrison Tsai
exaly   +4 more sources

The role of s-palmitoylation in neurological diseases: implication for zDHHC family. [PDF]

open access: yesFront Pharmacol, 2023
S-palmitoylation is a reversible posttranslational modification, and the palmitoylation reaction in human-derived cells is mediated by the zDHHC family, which is composed of S-acyltransferase enzymes that possess the DHHC (Asp-His-His-Cys) structural domain.
Liao D   +6 more
europepmc   +4 more sources

Adipocyte-Derived Palmitic Acid Promotes Breast Cancer Malignancy via ZDHHC15-Mediated S-Palmitoylation of PPARγ. [PDF]

open access: yesCancer Sci
Adipocyte‐derived palmitic acid induces ZDHHC15‐mediated PPARγ S‐palmitoylation at Cys159, triggering its proteasomal degradation and promoting breast cancer malignancy with rosiglitazone resistance. Inhibition of PPARγ S‐palmitoylation by 2‐bromopalmitate suppresses breast cancer progression and synergistically enhances rosiglitazone efficacy ...
Moon GH   +6 more
europepmc   +2 more sources

ZDHHC18-Mediated Palmitoylation of ORF3a Promotes SARS-CoV-2 Pathogenesis by Antagonizing TRIM16-Mediated Ubiquitination and Proteasomal Degradation. [PDF]

open access: yesAdv Sci (Weinh)
Palmitoylation by ZDHHC18 blocks ORF3a K27‐linked ubiquitination mediated by TRIM16, thereby preventing its proteasomal degradation and strengthening viral pathogenesis. Targeting palmitoylation through a pharmacological inhibitor (2‐BP), a competitive inhibitory peptide (OPIP), or adenovirus‐mediated knockdown of ZDHHC18 expression presents a ...
Yang S   +17 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy